Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke
- 1 November 1990
- journal article
- Published by Elsevier in The Lancet
- Vol. 336 (8725) , 1205-1209
- https://doi.org/10.1016/0140-6736(90)92829-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction.Stroke, 1990
- Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats.Stroke, 1989
- Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.BMJ, 1989
- Low dose blockade in acute stroke ("BEST" trial): an evaluationBMJ, 1988
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Measuring disability after a stroke.Journal of Epidemiology and Community Health, 1985
- The effects of nimodipine on the clinical course of patients with acute ischemic strokeActa Neurologica Scandinavica, 1984
- Flow thresholds of functional and morphological damage of brain tissue.Stroke, 1983
- Effect of nimodipine (Bay e 9736) on postischaemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF)Acta Neurochirurgica, 1982
- Effect of the Calcium Antagonist Nimodipine on Contractile Responses of Isolated Canine Basilar Arteries Induced by Serotonin, Prostaglandin F2α, Thrombin, and Whole BloodNeurosurgery, 1982